We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-3.69%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.23B
AUM Growth
+$247M
Cap. Flow
+$266M
Cap. Flow %
21.66%
Top 10 Hldgs %
61.87%
Holding
776
New
234
Increased
119
Reduced
104
Closed
282

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$172M
2
FCX icon
Freeport-McMoran
FCX
+$166M
3
TSLA icon
Tesla
TSLA
+$92.7M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$27.5M
5
PFE icon
Pfizer
PFE
+$25.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.5%
2 Healthcare 17.22%
3 Materials 15.97%
4 Technology 5.36%
5 Financials 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYRS
751
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
-6,683
Closed -$218K
GRTS
752
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
-13,797
Closed -$177K
SWAV
753
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-4,845
Closed -$864K
KAMN
754
DELISTED
Kaman Corp
KAMN
-4,884
Closed -$211K
EXPR
755
DELISTED
Express, Inc.
EXPR
-1,361
Closed -$84K
CHS
756
DELISTED
Chicos FAS, Inc.
CHS
-30,575
Closed -$164K
INFI
757
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-20,046
Closed -$45K
WWE
758
DELISTED
World Wrestling Entertainment
WWE
-9,590
Closed -$473K
AJRD
759
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-22,680
Closed -$1.06M
TCRR
760
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-22,784
Closed -$106K
PRVB
761
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-21,198
Closed -$119K
CSII
762
DELISTED
Cardiovascular Systems, Inc.
CSII
-19,814
Closed -$372K
LHCG
763
DELISTED
LHC Group LLC
LHCG
-7,153
Closed -$982K
RSX
764
CALL
DELISTED
VanEck Russia ETF
RSX
-31,700
Closed -$845K
MANT
765
DELISTED
Mantech International Corp
MANT
-10,870
Closed -$793K
ISBC
766
DELISTED
Investors Bancorp, Inc.
ISBC
-44,556
Closed -$675K
PBCT
767
DELISTED
People's United Financial Inc
PBCT
-20,475
Closed -$365K
VRS
768
DELISTED
Verso Corporation
VRS
-12,752
Closed -$345K
ACBI
769
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
-9,834
Closed -$283K
RRD
770
DELISTED
RR Donnelley & Sons Co.
RRD
-21,075
Closed -$237K
GTS
771
DELISTED
Triple-S Management Corporation
GTS
-13,780
Closed -$492K
SC
772
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
-23,879
Closed -$1M
ARCH
773
DELISTED
Arch Resources, Inc.
ARCH
-6,379
Closed -$583K
REGI
774
DELISTED
Renewable Energy Group, Inc.
REGI
-10,873
Closed -$461K
MTL
775
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
-26,108
Closed -$83K

Similar funds

Caxton Associates (New York)'s Q1 2022 Portfolio in Review

As of Q1 2022, Caxton Associates (New York) held 776 positions worth $1.23B, up 25% from $982M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Caxton Associates (New York) deployed $266M of net new capital in Q1 2022, opening 234 new positions and adding to 119 existing holdings. Its largest new stake was Aptiv: 1,293,400 shares worth $155M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 4.8% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Amazon, an estimated $7.44M trimmed.

  • Caxton Associates (New York)'s largest Q1 2022 buy was Aptiv: 1,293,400 shares worth $155M.
  • Caxton Associates (New York) added most to Tesla in Q1 2022, an estimated $92.7M increase.
  • Caxton Associates (New York)'s biggest Q1 2022 reduction was Amazon, cutting an estimated $7.44M.
  • Caxton Associates (New York) fully exited State Street SPDR S&P 500 ETF Trust in Q1 2022, selling an estimated $79M.
  • Caxton Associates (New York)'s ten largest holdings make up 62% of its $1.23B portfolio in Q1 2022.
  • Caxton Associates (New York) opened 234 new positions and closed 282 in Q1 2022.
  • Caxton Associates (New York)'s portfolio value rose 25% quarter-over-quarter to $1.23B.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.